In Vitro Model at Centre of Antimicrobial Drug Development The key to de-risking and expediting the development and approval of new antimicrobials is a… Learn More
Read our Nature Publication on Eliapixant, a Selective P2X3 Receptor Antagonist Learn about our latest research on a selective P2X3 receptor antagonist for the treatment of… Learn More
Webinar: Robust and Comprehensive PK Prediction for Early Drug Discovery Watch our webinar to learn about exciting new developments in pharmacokinetic prediction and how to… Learn More
Webinar: Metabolites in Safety Testing Join us for an educational webinar on MIST strategy. Learn More
Transforming Toxicology Prediction using Panomics Learn about transcriptomics and how the technology is transforming DILI and toxicology prediction. Learn More
Evotec and Almirall enter into a multi-target alliance in medical dermatology May 18, 2022 Learn more
Evotec and Sernova announce exclusive strategic partnership for iPSC-based beta cell replacement therapy to advance a 'functional cure' for diabetes May 16, 2022 Learn more